Oracle Biosciences LLC is categorized under Commercial Biotechnical Research in Urbana, IL and active since 2011.
Oracle Biosciences LLC was established in 2011, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Commercial Biotechnical Research business, which does work in the B2B market, and is classified as a Commercial Biotechnical Research, under code number 541711 by the NAICS.
If you are seeking more information, feel free to contact Partha S Ray at the company’s single location by writing to 509 West University Avenue, Urbana, Illinois IL 61801 or by phoning (908) 625-5169. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Oracle Biosciences LLC |
| Contact Person: | Partha S Ray |
| Address: | 509 West University Avenue, Urbana, Illinois 61801 |
| Phone Number: | (908) 625-5169 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2011 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Biotechnical Research |
| SIC Code: | 8731 |
| NAICS Code: | 541711 |
| Share This Business: |
Oracle Biosciences LLC was started in 2011 to provide professional Commercial Biotechnical Research under the SIC code 8731 and NAICS code 541711. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Partha S Ray for inquiries that concern Oracle Biosciences LLC by calling the company number (908) 625-5169, as your correspondence is most welcome. Additionally, the physical location of the single location of Oracle Biosciences LLC can be found at the coordinates 40.116326,-88.214247 as well as the street address 509 West University Avenue in Urbana, Illinois 61801.
For its online presence, you may visit Oracle Biosciences LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.